Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
 Disease Category: Depression (Major/Severe)
Location: United States, IL

Trial Information

An 8-week, randomzied, double-blind, placebo-controlled, parallel-group, multi-center study of the efficacy and safety of agomelatine 0.5mg and 1mg sublingual tablets administered once daily in patients with Major Depressive Disorder (MDD).

The purpose of this study is to find out if two different doses of agomelatine are safe and tolerable, and can help people who have major depressive disorder. The study doctor will also give agomelatine to some people in this study to find out if taking agomelatine is better than taking placebo. Placebo is a tablet that looks like an active drug but has no drug or other active ingredient

Please contact Alexian Brothers for more information on participation.

Alexian Brothers Hospital Network
1786 Moon Lake Boulevard, Suite 200
Hoffman Estates, IL 60169
Phone: 847-230-3599
Email: philip.carona@alexian.net

View Map

Research Center Information: Alexian Brothers Hospital Network

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.